GlaxoSmithKline Pharmaceuticals Limited appointed Mr. Juby Chandy as a Whole-time Director.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,485 INR | +5.40% | +5.47% | +30.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.95% | 480.46Cr | |
+38.15% | 73TCr | |
-7.40% | 35TCr | |
+15.93% | 33TCr | |
-0.13% | 28TCr | |
+13.47% | 24TCr | |
+7.35% | 21TCr | |
-6.42% | 20TCr | |
+4.06% | 16TCr | |
-1.67% | 16TCr |
- Stock Market
- Equities
- GLAXO Stock
- News GlaxoSmithKline Pharmaceuticals Limited
- GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as A Whole-Time Director